Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Keywords
Coronavirus disease 2019
Cytokine release syndrome
Interleukin-6
Tocilizumab
Cited by (0)
© 2020 Elsevier Ltd. All rights reserved.